Shilpa Medicare is currently trading at Rs. 668.25, up by 8.95 points or 1.36% from its previous closing of Rs. 659.30 on the BSE.
The scrip opened at Rs. 663.90 and has touched a high and low of Rs. 683.90 and Rs. 660.55 respectively. So far 9952 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 686.00 on 28-Nov-2016 and a 52 week low of Rs. 355.00 on 20-Jan-2016.
Last one week high and low of the scrip stood at Rs. 686.00 and Rs. 620.00 respectively. The current market cap of the company is Rs. 5150.41 crore.
The promoters holding in the company stood at 56.89%, while Institutions and Non-Institutions held 15.35% and 27.76% respectively.
Shilpa Medicare has received its board's approval for raising funds up to Rs 175 crore by issuing equity shares on preferential basis to TA FII Investors, Mauritius at a price of Rs 570 per share. The Board of Directors at their meeting held on December 01, 2016, has also proposed to increase the investment limit for FIIs'/FPIs and registered foreign investors to 40 percent from the existing limit of 30 percent, subject to approval by shareholders. The company's extra ordinary general meeting (EGM) will be held on December 26, 2016.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |